MGP Ingredients (MGPI) Financials

MGP Ingredients’ latest quarter was a sharp step down from the company’s prior-year performance. In Q1 2026, revenue fell to $106.4 million from $121.7 million in Q1 2025 and $138.3 million in Q4 2025, while the company posted a net loss of $134.8 million, driven largely by a $179.5 million impairment charge. That compares with a small loss of $3.1 million in the year-ago quarter and modest profitability in late 2025.

The biggest takeaway is that the core business is still generating gross profit and operating cash flow, but accounting charges and weaker sales are overwhelming results. Gross profit was $33.6 million in Q1 2026, down from $43.3 million a year ago, and operating income swung to a loss of $173.2 million. However, operating cash flow remained positive at $7.0 million, helped by non-cash adjustments.

• Operating cash flow stayed positive in Q1 2026 at $7.0 million, showing the business still generated cash from operations despite the reported loss.
• Gross profit remained solid at $33.6 million, indicating the company is still producing positive margin dollars before overhead and special charges.
• Debt came down versus the prior year in the first quarter, with long-term debt at $238.6 million versus $290.7 million at Q1 2025.
• SG&A and marketing were lower year over year than in Q1 2025, suggesting some expense discipline in the operating base.
• Inventory remains very high at $403.1 million, which may support near-term supply but also ties up a large amount of working capital.
• Accounts receivable also remained elevated at $86.6 million, another sign that a meaningful amount of capital is locked in working assets.
• Share count was roughly flat year over year, so dilution does not appear to be the main issue right now.
• Revenue declined sharply from Q1 2025 and also from the immediately prior quarter, showing weaker top-line momentum.
• The impairment charge of $179.5 million was the main driver of the quarterly loss and points to serious pressure on asset values or expected future earnings.
• Debt remains significant with total liabilities of $451.7 million and total debt still above $355 million combined, leaving less room for error if earnings stay weak.

Balance-sheet trends look mixed. Total assets were $1.03 billion, down sharply from $1.38 billion in Q3 2025, largely because goodwill and intangibles were written down or reduced. Equity also fell to $579.6 million from $853.5 million in Q3 2025. That kind of decline is consistent with a major impairment event and is usually a sign that management has lowered expectations for some part of the business.

Over the longer run, MGPI’s results have been volatile. In 2024, the company was still generating strong revenue and profits in several quarters, but 2025 turned choppier, with Q1 2025 showing a loss and Q3 2025 briefly recovering to profitability before the latest downturn. The current quarter suggests the recovery has not yet been sustained.

For retail investors, the key question is whether this is a temporary reset or a deeper reset in the earnings power of the company. The positive cash flow is encouraging, but the combination of lower revenue, a large impairment, and a much smaller equity base means investors will likely want to see stabilization in the next few quarters before assuming a durable turnaround.